ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,823, issued on Nov. 25, was assigned to ZHUHAI UNITED LABORATORIES Co. LTD. (Guangdong, China).
"Compound for use in retinal diseases" was invented by Peng Li (Shanghai), Xiaolin Li (Shanghai), Zhi Luo (Shanghai), Haiying He (Shanghai), Guoping Hu (Shanghai), Jian Li (Shanghai) and Shuhui Chen (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is an aldehyde binder, specifically, disclosed is a compound as represented by formula (II) or a pharmaceutically acceptable salt."
The patent was filed on Jan. 31, 2024, under Application No. 18/429,297.
*For further information, including images, charts and tables, please visit: http://patft...